DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 001
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ADENOSINE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX
|
XX
|
DRUG ACTION:
Blocks the AV node to slow conduction and treat reentry conditions (tachyarrhythmias)
INDICATIONS FOR USE
Symptomatic supraventricular tachycardia
CONTRAINDICATIONS
Allergy to the drug
Heart block
Drug-induced tachycardias (e.g. from cocaine)
Atrial Flutter and Atrial Fibrillation
SIDE EFFECTS
Headache
Facial flushing
Chest pressure
Nausea
SPECIAL NOTES:
Very short duration of action, must enter the circulation and get to the heart within 10-20
seconds
Pregnancy category C
USUAL DOSE
Adult: 6 mg IV bolus followed by 10-20 ml flush; second dose 12 mg IV bolus followed by flush
Pediatric: 0.1 mg/kg IV bolus followed by a 10-20 ml flush, maximum of 6 mg; second dose 0.2
mg/kg followed by flush, maximum 12 mg
MONITOR, REPORT, DOCUMENT
Continuous ECG
Attempt to capture conversion on ECG paper
Vital signs before and within 5 minutes after administration.
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 002
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ALBUTEROL
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX
|
XX
|
XX
|
XX
|
DRUG ACTION:
Bronchodilator
INDICATIONS FOR USE
Acute bronchospasm (asthma, COPD)
CONTRAINDICATIONS
Allergy to the drug
SIDE EFFECTS
Headache
Tachycardia
Hypertension
SPECIAL NOTES:
Monitor patients with cardiovascular disease
Pregnancy category C
USUAL DOSE
Adult and Pediatric: 2.5 mg (O.5 ml) nebulized with 2.5 ml saline (total of 3 ml)
MONITOR, REPORT, DOCUMENT
Monitor ECG in patients with cardiac history or over age 45
Vital signs within 5 minutes of administration and at completion of treatment
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 003
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
AMIODARONE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX - bolus only
|
XX
|
DRUG ACTION:
Antiarrhythmic
INDICATIONS FOR USE:
Ventricular tachycardia, ventricular fibrillation {Intermediate and Paramedic}
Wide complex Atrial Fib/Flutter (ie greater than 160 bpm) {Paramedic only – on line medical control}
CONTRAINDICATIONS:
Allergy to the drug
Heart block
Bradycardia
Neonates, infants
Known or suspected drug-induced dysrhythmia (e.g. from cocaine)
Cyclic drug usage
SIDE EFFECTS:
Bradycardia
Hypotension
Congestive heart failure
Heart block
SPECIAL NOTES:
Pregnancy category D
USUAL DOSE:
300 mg IVP for ventricular fibrillation or pulseless ventricular tachycardia (may repeat 150mg IVP once in 3-5 minutes if needed) 150 mg IV bolus over 10 minute period for stable ventricular tachycardia (consider dilution in 250 ml or less of NS and run piggyback IV drip for ease of administration) 1 mg/min drip for maintenance Pediatric: 5 mg/kg
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs within 5 minutes before and after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 004
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ASPIRIN (ACETYLSALICYLIC ACID, ASA)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX
|
XX
|
XX
|
XX
|
DRUG ACTION:
Anti-inflammatory
Relieves fever
Impedes blood clotting
INDICATIONS FOR USE
Given to patients with signs/symptoms of ischemic chest pain (suspected myocardial infarction)
CONTRAINDICATIONS
Allergy to the drug
Bleeding disorders
Affirmative answer to any question in the special note section below.
(Note: Should not be given to children with fever associated with acute viral illness – Reye’s Syndrome)
SIDE EFFECTS
Nausea
Gastrointestinal bleeding
Rash
Tinnitus
SPECIAL NOTES:
Low doses are more effective for anti-clotting effect
Ask patient:
Have you taken any aspirin already today?
Are you allergic to aspirin?
Do you have any bleeding disorder?
Pregnancy category D
USUAL DOSE
162-324 mg chewable tables (2-4 baby aspirin)
MONITOR, REPORT, DOCUMENT
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 005
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
ATROPINE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX
|
XX
|
DRUG ACTION:
Block the effects of the vagus nerve (blocks parasympathetic nerve)
INDICATIONS FOR USE
Symptomatic bradycardia, heart blocks, asystole (adults), Pulseless electrical activity with a slow rate
Organophosphate poisoning
CONTRAINDICATIONS
Allergy to the drug
Glaucoma
Heart Blocks with QRS complexes greater than 0.12 mm
SIDE EFFECTS
Palpitations
Tachycardia
Blurred vision
Dry mouth
Elevated blood pressure
SPECIAL NOTES:
Pregnancy category C
USUAL DOSE
Adults: 0.5-1 mg for cardiac; 2-3 mg for organophosphate poisoning
Pediatric: 0.02 mg/kg (for rhythms associated with activities causing increased vagal tone)
Minimum dose 0.1 mg
MONITOR, REPORT, DOCUMENT
Pulse rate before and after administration
Vital signs within 5 minutes after administration
Continuous ECG
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 006
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
DEXTROSE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
Oral only
|
XX
|
XX
|
XX
|
DRUG ACTION:
Provides calories for metabolic needs
INDICATIONS FOR USE
Hypoglycemia
CONTRAINDICATIONS
Increased intracranial pressure
Alcoholic in delirium tremors
SIDE EFFECTS
Hyperglycemia
SPECIAL NOTES:
Will cause tissue sloughing if infiltrated
Must be diluted before administration to children
Especially in children, IM Glucagon should be considered prior to attempting peripheral IV and IV Dextrose.
Consider Thiamine in malnourished or suspected alcoholics
USUAL DOSE:
-
In the patient greater than100 pounds with an altered level of consciousness, who is unable to safely take oral glucose and with a blood glucose level less than 60 mg/dL, administer 25 grams Dextrose IV bolus.
-
In the patient less than100 pounds but at least 2 years old, Glucagon IM should be considered prior to attempting an IV and giving Dextrose. If Dextrose is indicated, administer 500 mg/kg (0.5 grams/kg) Dextrose diluted 1:1 with NS. Draw up the dose calculated into a large syringe and dilute (draw into the same syringe) with an equal volume of NS. For patients younger than 2 years, contact medical control for appropriate dose and dilution of dextrose (deleted reference to ml/kg).
-
In the patient who can safely eat or drink, oral glucose (Glutose) replacement is preferred.
-
Instruct patient that the gel must be swallowed
-
Allow patient to self-administer gel incrementally or assist with squeezing gel into patient’s mouth incrementally.
-
Repeat as necessary until you arrive at the hospital or mental status is normal and blood sugar is equal to or greater than 80 mg/dL.
-
If the patient is not responding to oral glucose and blood sugar continues to be low, consider IV dextrose administration.
-
For patients in whom an IV cannot be established:
-
For patients who weigh more than 44 pounds, administer 1 mg Glucagon IM (see drug profile # 011).
- For pediatric patients (less than 44 pounds) administer 0.5 mg Glucagon IM (See drug profile # 011)
MONITOR, REPORT, DOCUMENT
Changes in level of consciousness
Blood sugar before and after treatment
Vital signs within 5 minutes after administration
Watch carefully for infiltration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 007
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
DIAZEPAM (VALIUM)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX – For Seizures only
|
XX
|
DRUG ACTION:
Central nervous system depressant
Muscle relaxant
INDICATIONS FOR USE
Continuous or recurrent seizures, status epilepticus
Sedation for procedures
CONTRAINDICATIONS
Allergy to the drug
Hypotension
Altered level of consciousness
Intoxication
SIDE EFFECTS
Hypotension
Rash
Respiratory depression
Bradycardia
SPECIAL NOTES:
Controlled substance (federal regulations), addictive
Pregnancy category D
USUAL DOSE
Adult: 2-5 mg IV, (rectally if unable to establish an IV line)
Pediatric: 0.05-0.1 mg/kg IV, maximum of 8 mg.
0.5 mg/kg rectally, maximum of 20 mg [Can use an equal dose of Diastat (rectal diazepam gel)]
MONITOR, REPORT, DOCUMENT
Vital signs and respiratory assessment within 5 minutes after administration
Altered level of consciousness
Seizure activity
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 008
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
DIPHENHYDRAMINE (BENADRYL)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Antihistamine, blocks histamine’s effect on smooth muscle in the respiratory, circulatory and gastrointestinal systems. Histamine causes bronchoconstriction, vasodilation and GI spasms
INDICATIONS FOR USE
Allergic reactions
CONTRAINDICATIONS
Allergy to drug
Glaucoma
Newborns
SIDE EFFECTS
Drowsiness, confusion
Seizures
Tachycardia
Blurred vision
Nausea, vomiting
SPECIAL NOTES:
Pregnancy category B
USUAL DOSE
12 and older: 25-50 mg IV or PO
Younger than 12 years old: 1.25 mg/kg, maximum of 25 mg IV or PO
MONITOR, REPORT, DOCUMENT
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 009
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
EPINEPHRINE (ADRENALIN)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX (IM 1:1,000) for anaphylaxis*
|
XX (IM 1:1000) for anaphylaxis
|
XX
|
XX
|
*Requires Operational Plan if not using auto-injector
DRUG ACTION:
Increases heart rate and force
Vasoconstriction
Bronchodilation
INDICATIONS FOR USE
Asthma (1:1000 IM) (EMT-Intermediate and Paramedic only)
Anaphylaxis (1:1000 IM)
Patients in cardiopulmonary arrest while CPR is in progress (IV bolus 1:10,000) (Intermediate and Paramedic only)
CONTRAINDICATIONS
Glaucoma
Shock other than anaphylactic
SIDE EFFECTS
Headache
Palpitations
Hypertension
Tachycardia
SPECIAL NOTES:
Don’t mix with alkaline solutions (sodium bicarbonate)
Epi-Pen = 0.3 mg
Epi-Pen Jr. = 0.15 mg (less than 60 pounds)
Pregnancy category C
USUAL DOSE
IM dose (1:1,000) (1 mg in 1 ml)
0.1-0.3mg 1:1000 for anaphylaxis. For asthma (Intermediate and Paramedic use only),
May repeat in 5 minutes if no improvement or worsening of condition with medical control
approval
IV/IO dose (1:10,000) (1 mg in 10 ml) Cardiopulmonary arrest
Adult: 1 mg IV/IO, 2 mg ET
Pediatrics less than 60 pounds:
0.01 mg/kg dose, 0.1 mg/kg ET dose
MONITOR, REPORT, DOCUMENT
Breath sounds, vital signs within 5 minutes after administration
Effect on heart rate
Continuous ECG monitoring
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 010
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
FUROSEMIDE (LASIX)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX
|
XX
|
DRUG ACTION:
Diuretic
INDICATIONS FOR USE
Not recommended for routine pre-hospital treatment of acute congestive heart failure/pulmonary edema unless diagnosis of CHF/pulmonary edema confirmed
CONTRAINDICATIONS
Allergy to the drug
Anuria (no urine output, e.g. dialysis patient)
Hypotension (Systolic BP less than 90 mmHg)
SIDE EFFECTS
Hypotension
Rash
SPECIAL NOTES:
Long term use can result in electrolyte imbalance and dehydration
Use with caution in patients with allergy to sulfa drugs
Pregnancy category C
USUAL DOSE
40 mg IV bolus
MONITOR, REPORT, DOCUMENT
Daily maintenance dose
Vital signs, respiratory assessment within 5 minutes after administration
Any urinary output
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 12/08
|
Profile Number: 011
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
GLUCAGON
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX **optional**
|
XX
|
XX
|
XX
|
DRUG ACTION:
Raises blood glucose by stimulating liver to release stored glycogen (sugar) and converting fats and proteins to glucose
INDICATIONS FOR USE
Hypoglycemia
CONTRAINDICATIONS
Allergy to the drug
History of pheochromocytoma (tumor which secretes epinephrine)
SIDE EFFECTS
Hypotension
Nausea, vomiting
Respiratory distress
SPECIAL NOTES:
May be repeated in 20 minutes if no response. IV glucose must be given if patient doesn’t respond to glucagon.
Drug is supplied in a powdered form and must be reconstituted in the solution supplied with the powder.
Patient needs to eat carbohydrates as soon as awake and able to swallow safely.
In the pediatric patient, IM Glucagon should be administered prior to attempting peripheral IV and IV Dextrose.
Pregnancy category B
USUAL DOSE
In the patient who can safely eat or drink, oral glucose replacement is preferred.
Instruct patient that the gel must be swallowed
Allow patient to self-administer gel incrementally or assist with squeezing gel into patient’s mouth incrementally.
Repeat as necessary until tube content has been consumed.
For patients in whom an IV cannot be established:
For patients who weigh more than 44 pounds, administer 1 mg Glucagon IM.
For pediatric patients (less than 44 pounds) administer 0.5 mg Glucagon IM Intranasal dosing same as above IM dosing
MONITOR, REPORT, DOCUMENT
Vital signs within 5 minutes after administration
Changes in level of consciousness Blood sugar before and after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 012
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
LIDOCAINE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX-bolus only
|
XX
|
DRUG ACTION:
Antiarrhythmic (ventricular)
INDICATIONS FOR USE
Ventricular arrhythmias (PVCs, ventricular tachycardia, ventricular fibrillation)
Local and bone marrow anesthetic for placement of IO line
CONTRAINDICATIONS
Allergy to this or other “caine” drug
Heart blocks
SIDE EFFECTS
Seizures
Hypotension
Bradycardia
SPECIAL NOTES:
If allergic to other local anesthetics (e.g. Novocain), contact medical control prior to administration
Pregnancy category B
USUAL DOSE
1-1.5 mg/kg IV, maximum dose 3 mg/kg
2-4 mg/min maintenance dose
For IO placement:
0.5-1 ml 2% solution infiltrated subcutaneously at IO site
Adult: 20-40 mg (1-2 ml) of 2% Lidocaine IO bolus over one minute
Pediatric: 0.5 mg/kg of 2% Lidocaine IO bolus
Note: 2% Lidocaine = 20 mg/ml
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 013
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
MORPHINE SULFATE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX
|
XX
|
DRUG ACTION:
Long acting narcotic analgesic (pain relief)
Central nervous system depressant
INDICATIONS FOR USE
Chest pain of cardiac origin
Burns (moderate to severe pain)
Extremity trauma (moderate to severe pain)
Contact medical control prior to any other use
CONTRAINDICATIONS
Allergy to the drug
Hypotension
Head, chest, abdominal trauma
Respiratory depression
SIDE EFFECTS
Decreased level of consciousness
Bradycardia
Hypotension
Nausea, vomiting
Respiratory depression
SPECIAL NOTES:
Addictive, federal regulations apply
Can be reversed with naloxone (see drug profile 014)
Pregnancy category C (D in long-term use or high dose)
USUAL DOSE
2-5 mg slow IV bolus over 2-3 minutes, may be repeated for severe pain (adult)
0.05 mg/kg (pediatric)
MONITOR, REPORT, DOCUMENT
Effect on pain level
Effect on respiratory rate and effort
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 014
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
NALOXONE (NARCAN)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
XX
|
XX
|
XX
|
DRUG ACTION:
Reverses narcotic-induced respiratory depression and altered level of consciousness
INDICATIONS FOR USE
Suspected narcotic overdose in patients with altered level of consciousness
CONTRAINDICATIONS
Allergy to the drug
SIDE EFFECTS
Tremors
Tachycardia
Nausea, vomiting
SPECIAL NOTES:
May induce narcotic withdrawal in addicts (Nausea, vomiting, diaphoresis, tachycardia, hypertension)
Duration of action of naloxone may be shorter than the narcotic and the patient may relapse
Consider contact of Poison Control (1-800-222-1222).
Pregnancy category C
USUAL DOSE
Adults: 0.4 – 2 mg slow IV, IM, repeated in 2-3 minutes
Pediatric: 0.01 mg/kg first dose; 0.1 mg/kg second and subsequent doses, maximum dose 2 mg
Intranasal dose same as IV/IM dosing
MONITOR, REPORT, DOCUMENT
Changes in level of consciousness
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 015
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
NITROGLYCERIN
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX (Patient assisted) *
|
XX
|
XX
|
XX
|
*Requires Operational Plan
DRUG ACTION:
Vasodilator
Decreases venous return
INDICATIONS FOR USE
Chest pain of cardiac origin (ischemic), angina
Acute congestive heart failure
CONTRAINDICATIONS
Hypotension (systolic pressure less than 100 mm/Hg)
Use of sildenafil (Viagra) within the past 24 hours
Use of tadalafil (Cialis) or vardenafil (Levitra) within past 48 hours
SIDE EFFECTS
Headache
Hypotension (systolic pressure less than 100 mm/Hg)
Tachycardia
SPECIAL NOTES:
Drug is sensitive to light and moisture IV access should be established prior to administration of nitroglycerine unless vital signs are stable and you are assisting the patient in taking his/her own medication. Pregnancy category C
USUAL DOSE
Adults: 0.4 mg sublingually, may repeat every 3-5 minutes for 15 minutes. Check with medical control for additional doses.
MONITOR, REPORT, DOCUMENT
Vital signs and pain assessment within 5 minutes after administration
Blood pressure before and after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 016
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
PROCAINAMIDE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Antiarrhythmic
INDICATIONS FOR USE
Ventricular tachycardia, ventricular fibrillation, PVCs
CONTRAINDICATIONS
Allergy to the drug
Heart block
Torsades des pointes
SIDE EFFECTS
Hypotension
Bradycardia
Heart block
Nausea, vomiting
Rash
SPECIAL NOTES:
Monitor the width of the QRS and the blood pressure
Pregnancy category C
USUAL DOSE
Adult: 50-100 mg IV bolus over 5 minute period until:
QRS is 50% wider than at start of medication administration
Maximum dose of 17 mg/kg has been given
Effect on dysrhythmia achieved
Special pediatric considerations: 15 mg/kg over 30-60 minutes only for ventricular tachycardia
with pulses
MONITOR, REPORT, DOCUMENT
QRS duration
ECG changes
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 017
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
SODIUM BICARBONATE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Neutralizes acids
INDICATIONS FOR USE
Treat metabolic acidosis associated with cardiopulmonary arrest
Ventricular dysrhythmias secondary to cyclic antidepressants
CONTRAINDICATIONS
Alkalosis
SIDE EFFECTS
Alkalosis
SPECIAL NOTES:
Must be diluted for neonates
Pregnancy category C
USUAL DOSE
1 mEq/kg
MONITOR, REPORT, DOCUMENT
Changes in level of consciousness
ECG changes
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 018
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
AMMONIA INHALANTS
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX
|
XX
|
XX
|
XX
|
DRUG ACTION:
Olfactory stimulant, reflex respiratory stimulant, elevates blood pressure
INDICATIONS FOR USE
Patient who presents with an altered level of consciousness after other physical causes have been ruled out.
CONTRAINDICATIONS
Patient is alert and oriented
Medical cause for the altered level of consciousness has been established
SIDE EFFECTS
Irritation of respiratory membranes, pharynx, esophagus
SPECIAL NOTES:
Rule out all medical and traumatic causes for altered level of consciousness before using ammonia inhalants
DO NOT insert ammonia inhalants into any orifice or place under oxygen mask
May irritate patient
USUAL DOSE
One capsule, broken and waved under the patient’s nose during inhalation
MONITOR, REPORT, DOCUMENT
Change in level of consciousness
Vital signs within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 019
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
IPRATROPIUM (ATROVENT)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
XX **
|
XX
|
XX
|
XX
|
**optional**
DRUG ACTION:
Bronchodilator
INDICATIONS FOR USE
Maintenance therapy in patients with Chronic Obstructive Pulmonary Disease (COPD)
Bronchospasm
CONTRAINDICATIONS
Allergy to the drug, soybeans, peanuts
Glaucoma
SIDE EFFECTS
Dry mouth
Headache
Nausea, vomiting, cramping
Tachycardia
SPECIAL NOTES:
Most often used in combination with or immediately following albuterol
Not recommended to be used alone in acute respiratory distress
May use pre-mixed combination with Albuterol for first adult treatment (ie “Duo-Neb”)
Pregnancy category B
USUAL DOSE
0.5 mg nebulized with 2.5 ml saline (total of 3 ml)
0.25 mg nebulized for children less than 12 years of age
MONITOR, REPORT, DOCUMENT
Monitor ECG in patients with cardiac history or over age 45
Vital signs and breath sounds within 5 minutes of administration and at completion of treatment
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision:: 11/08
|
Profile Number: 020
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
VASOPRESSIN
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
XX
|
XX
|
DRUG ACTION:
Peripheral vasoconstriction
INDICATIONS FOR USE
Cardiac arrest patients in ventricular fibrillation, pulseless ventricular tachycardia, asystole or pulseless electrical activity (as an option in place of initial or second dose of epinephrine)
CONTRAINDICATIONS
Conscious patients with coronary artery disease
Allergy
SIDE EFFECTS
Pallor
Bronchial constriction
Uterine contraction
SPECIAL NOTES:
Vasopressin may be given in place of the 1st or 2nd dose of epinephrine (see drug profile #009) in the cardiac resuscitation protocol
Pregnancy category C
USUAL DOSE
Adults: 40 Units IV or IO, one dose only
MONITOR, REPORT, DOCUMENT
Electrocardiogram
Vital signs and breath sounds within 5 minutes of administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 021
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
CALCIUM CHLORIDE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Cardiac stimulant, increases force of contraction
Calcium as an element is required for many physiological activities
INDICATIONS FOR USE
Calcium channel blocker overdose
Elevated potassium (hyperkalemia)
Low calcium (hypocalcemia)
CONTRAINDICATIONS
Patient taking digitalis (Use with caution)
Ventricular tachycardia
Ventricular fibrillation
SIDE EFFECTS
Bradycardia
Arrhythmias
Syncope
Cardiac arrest
SPECIAL NOTES:
Flush line before administering sodium bicarbonate (causes precipitation)
Be sure the IV is not infiltrated, causes tissue sloughing
Pregnancy category C
USUAL DOSE
Adult: 100-500 mg IV bolus
Pediatric: 20 mg/kg, maximum dose 500 mg
MONITOR, REPORT, DOCUMENT
Continuous ECG
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 022
|
Service Director’s
Signature
|
|
Medical Director’s
Signature
|
|
The following is the basic information and guideline for use of:
THIAMINE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Allows breakdown of Glucose
INDICATIONS FOR USE:
Alcoholic patients and those who are malnourished
CONTRAINDICATIONS:
Allergy to the drug
SIDE EFFECTS: n/a
SPECIAL NOTES:
Helpful prior to administration of glucose in alcoholic or those malnourished
Pregnancy category A
USUAL DOSE:
100 mg IVP
MONITOR, REPORT, DOCUMENT:
Vital signs before and within 5 minutes after administration
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 1/05/09
|
Profile Number: 023
|
Service Director’s
Signature
|
|
Medical Director’s
Signature
|
|
The following is the basic information and guideline for use of:
Midazolam (Versed)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Central nervous system depressant
INDICATIONS FOR USE:
Sedation for patients prior to intubation and cardioversion
Seizure management
CONTRAINDICATIONS:
Allergy to the drug
hypotension
SIDE EFFECTS:
Hypotension, respiratory depression, bradycardia, disinhibition resulting in agitation
SPECIAL NOTES:
Always have advanced airway equipment ready prior to use. Always preoxygenate prior to use. Can reverse with Romazicon (see drug profile 025)
Pregnancy category D
USUAL DOSE:
Adults – 2-5 mg
Maximum RSI dose 10 mg.
Seizures: 2-5 mg IV/IM (may repeat in 5 minutes) (Titrate IV bolus dose to effect)
Pediatrics – 0.05 mg/kg (not to exceed adult dose)
Seizures: 0.05 mg/kg-0.1 mg/kg IV/IM (may repeat in 5 minutes)(Titrate IV bolus
dose to effect)
Rectal Dose 0.1 mg/kg; maximum total dose 5 mg
Intranasal dose: Same as IV dose
MONITOR, REPORT, DOCUMENT:
Continuous ECG and Oxygen Saturation monitoring.
Vital signs before and within 5 minutes after administration.
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 024
|
Service Director’s
Signature
|
|
Medical Director’s
Signature
|
|
The following is the basic information and guideline for use of:
DOPAMINE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Vasoconstriction
Low doses cause renal and mesenteric vasodilation
Increases force of contraction of heart to increase cardiac output
INDICATIONS FOR USE:
Hypotension not associated with hypovolemia
CONTRAINDICATIONS:
Allergy to the drug
Tachydysrhythmia
Ventricular fibrillation
Hypovolemia
SIDE EFFECTS:
Hypertension, tachydysrhythmia (dose related), increased myocardial oxygen demand
SPECIAL NOTES:
If hypotension related to hypovolemia, tachydysrhythmia are very common.
MAO’s may potentiate the effect of Dopamine
Pregnancy category C
USUAL DOSE:
Mix 400 mg in 250 cc of normal saline and titrate for effect
Typical range 5-10 mcg/kg/min
Titrate dose to BP systolic of 100 mmHg
MONITOR, REPORT, DOCUMENT:
Continuous ECG
Vital signs before and within 5 minutes after administration.
END
DRUG PROFILE
Initial Date: 11/01/01
|
Last Review/Revision: 11/08
|
Profile Number: 025
|
Service Director’s
Signature
|
|
Medical Director’s
Signature
|
|
The following is the basic information and guideline for use of:
Flumazenil (ROMAZICON)
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Reversal of sedative effects of benzodiazepines
INDICATIONS FOR USE:
Known pure benzodiazepine overdose, Versed reversal
To be used only with the approval of on-line medical control
CONTRAINDICATIONS:
Allergy to the drug
Cyclic antidepressant overdose, mixed overdose, dysrhythmias, wide QRS, chronic benzodiazepine use
SIDE EFFECTS:
Headache, dizziness, dysrhythmias, seizures, vomiting
SPECIAL NOTES:
Used in patients with respiratory failure secondary to pure benzodiazepine overdose.
Not to be used as part of routine unresponsive patient care. Contact medical control before administration
Pregnancy category C
USUAL DOSE:
Initial dose 0.2 mg IVP. Repeat dose to max of 1 mg if needed
MONITOR, REPORT, DOCUMENT:
Continuous ECG
Vital signs before and within 5 minutes after administration.
END
DRUG PROFILE
Initial Date: 12/05/2002
|
Last Review/Revision: 11/08
|
Profile Number: 026
|
Service Director’s Signature
|
|
Medical Director’s Signature
|
|
The following is the basic information and guideline for use of:
MAGNESIUM SULFATE
-
Approved for use by:
|
EMT
|
Advanced EMT
|
EMT-Intermediate
|
Paramedic
|
|
|
|
|
XX
|
DRUG ACTION:
Central nervous system depressant, anticonvulsant, antiarrhythmic, bronchial smooth muscle relaxant
INDICATIONS FOR USE
Obstetrical: Eclampsia
Cardiovascular: Refractory ventricular fibrillation or pulseless ventricular tachycardia, torsades
de pointes
Respiratory: Status asthmaticus
CONTRAINDICATIONS
|